Investors Overview

Corporate Profile
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit
ExchangeTSX (Canadian Dollar)
Change (%) Stock is Up 0.02 (0.36%)
Data as of 05/19/17 3:56 p.m. ET
Refresh quote
Recent NewsMore >>
05/12/17Cipher Pharmaceuticals Reports Voting Results from Annual and Special Meeting of ShareholdersPrinter Friendly Version
05/11/17Cipher Pharmaceuticals Reports Q1 2017 Financial ResultsPrinter Friendly Version
05/08/17Cipher Pharmaceuticals Receives Health Canada Approval of OZANEX™ (ozenoxacin cream 1%) Printer Friendly Version
Featured Documents
Download Documentation 2016 AGM Presentation
Download Documentation Q1 Financial Statements
Download Documentation Q1 MD&A
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Cipher Pharmaceuticals Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources